|
|
News Breaks | | | | December 19, 2012 | | 07:32 EDT |  | VPHM, HALO | ViroPharma, Halozyme announce initiation of Phase 2b dose to evaluate Cinryze
ViroPharma (VPHM) and Halozyme (HALO) announced that ViroPharma has initiated its Phase 2b double blind, multicenter, dose ranging study to evaluate the safety and efficacy of subcutaneous administration of Cinryze in combination with Halozyme's Enhanze technology in adolescents and adults with hereditary angioedema for prevention of HAE attacks. This double blind, cross-over, dose ranging study will be conducted in approximately 40 adolescent and adult subjects in the U.S. and Europe. The primary efficacy endpoint is the normalized number of angioedema attacks recorded during each treatment period. In addition, several secondary endpoints will be assessed, including attack severity, quality of life parameters using a novel angioedema tool, and number of angioedema attacks requiring acute treatment. | |
|
News For VPHM;HALO From The Last 14 Days Check below for free stories on VPHM;HALO the last two weeks. |
|
|
| June 17, 2013 | | 16:20 EDT |  | VPHM | On The Fly: Closing Wrap
Stocks on Wall Street were higher following a session dominated by speculation over what is next for the Federal Reserve. The averages trimmed their gains after an article by the Financial Times suggested the Fed would signal a tapering of its pace of asset purchases at its Wednesday press conference. The upward trend resumed after the article's author said the report was based on opinion and that, "The Fed does not leak anything to any journalist to steer markets - especially during blackout." ECONOMIC EVENTS: In the U.S., the New York Fed Empire State Survey for June came in at 7.40, versus expectations for a 0 reading. The NAHB housing market confidence index for June rose to 52, versus the forecast for a more modest climb to 45 from its prior 44 reading. In Europe, Germany's Bundesbank said economic indicators for April pointed to robust growth in the second quarter and business sentiment improved in May, though warned of signs that growth in Europe's largest economy would slow over the summer. COMPANY NEWS: Netflix (NFLX) and DreamWorks (DWA) both climbed after announcing a major content deal. Under the agreement, DreamWorks will provide over 300 hours of content to Netflix, which the TV and movie service expects to start broadcasting next year. After the announcement, Netflix rose $15.24, or 7.12%, to $229.23, while DreamWorks added 93c, or 4.08%, to $23.74. MAJOR MOVERS: Among the notable gainers was Kandi Technologies (KNDI), up $1.53, or 24.4%, to $7.80 after saying it will deploy 5K-10K pure electric vehicles in China within the first year of launch. Also higher were shares of ViroPharma (VPHM), up $1.71, or 6.3%, to $28.87 after Reuters said the company has attracted takeover interest, though the company is not pursuing a sale. Among the noteworthy losers was Terex (TEX), down $2.45, or 7.72%, to $29.29 after the company lowered it fiscal year earnings view. Also lower was Medivation (MDVN), down $3.45, or 6.78%, to $47.41 after Johnson & Johnson (JNJ) acquired the company's competitor, privately held Aragon Pharmaceuticals. INDICES: The Dow was up 109.67, or 0.73%, to 15,179.85; the Nasdaq was up 28.57, or 0.83%, to 3,452.13; and the S&P 500 was up 12.31, or 0.76%, to 1,639.04. | | | 13:40 EDT |  | VPHM | ViroPharma June calls active on attracting takeover interest
ViroPharma June 30 calls are active on total call volume of 1,900 contracts (210 puts). June call option implied volatility is at 58, July and August is at 48, November is at 39; above its 26-week average of 37 according to Track Data, suggesting larger price movement on the company not pursuing a sale but attracting takeover interest, Reuters says. | | | 11:37 EDT |  | VPHM | ViroPharma not pursuing sale but attracting takeover interest, Reuters says
 Subscribe for More Information | | | 11:34 EDT | | VPHM | ViroPharma up 9% after Reuters report of takeover interest
Subscribe for More Information | | | 11:33 EDT | | VPHM | ViroPharma has attracted preliminary takeover interest, Reuters reports
Subscribe for More Information | | | June 11, 2013 | | 06:20 EDT | | VPHM | ViroPharma receives Orphan drug designation for Maribavir in Europe
Subscribe for More Information | | | June 5, 2013 | | 07:08 EDT | | HALO | Spectrum names Kurt Gustafson as CFO effective immediately
Subscribe for More Information | |
|
|
|
|
|
|
